{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T06:45:00Z","timestamp":1793861100360,"version":"4.6.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Nanotechnol."],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1038\/s41565-024-01851-7","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T10:02:56Z","timestamp":1739181776000},"page":"543-553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":95,"title":["Customizable virus-like particles deliver CRISPR\u2013Cas9 ribonucleoprotein for effective ocular neovascular and Huntington\u2019s disease gene therapy"],"prefix":"10.1038","volume":"20","author":[{"given":"Sikai","family":"Ling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1999-8687","authenticated-orcid":false,"given":"Zhuofan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xujiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9054-7303","authenticated-orcid":false,"given":"Sicong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7336-3895","authenticated-orcid":false,"given":"Jianping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5628-5849","authenticated-orcid":false,"given":"Niklas","family":"Selfjord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9021-1650","authenticated-orcid":false,"given":"Tugce Munise","family":"Satir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Lundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Liz","family":"Touza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike","family":"Firth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Van Zuydam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilada","family":"Bilican","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8413-8995","authenticated-orcid":false,"given":"Pinar","family":"Akcakaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-633X","authenticated-orcid":false,"given":"Jiaxu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2955-7289","authenticated-orcid":false,"given":"Yujia","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"1851_CR1","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1056\/NEJMoa2107454","volume":"385","author":"JD Gillmore","year":"2021","unstructured":"Gillmore, J. D. et al. CRISPR\u2013Cas9 in vivo gene editing for transthyretin amyloidosis. N. Engl. J. Med. 385, 1721\u20131722 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1851_CR2","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1016\/j.ymthe.2023.08.021","volume":"31","author":"A Wei","year":"2023","unstructured":"Wei, A. et al. In vivo CRISPR gene editing in patients with herpetic stromal keratitis. Mol. Ther. 31, 3163\u20133175 (2023).","journal-title":"Mol. Ther."},{"key":"1851_CR3","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMoa2309915","volume":"390","author":"EA Pierce","year":"2024","unstructured":"Pierce, E. A. et al. Gene editing for CEP290-associated retinal degeneration. N. Engl. J. Med. 390, 1972\u20131984 (2024).","journal-title":"N. Engl. J. Med."},{"key":"1851_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-20278-4","volume":"8","author":"S Becker","year":"2018","unstructured":"Becker, S. et al. Targeted knockdown of overexpressed VEGFA or VEGF164 in Muller cells maintains retinal function by triggering different signaling mechanisms. Sci. Rep. 8, 2003 (2018).","journal-title":"Sci. Rep."},{"key":"1851_CR5","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41586-020-2388-4","volume":"582","author":"H Qian","year":"2020","unstructured":"Qian, H. et al. Reversing a model of Parkinson\u2019s disease with in situ converted nigral neurons. Nature 582, 550\u2013556 (2020).","journal-title":"Nature"},{"key":"1851_CR6","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1038\/s41588-021-00838-7","volume":"53","author":"ML Leibowitz","year":"2021","unstructured":"Leibowitz, M. L. et al. Chromothripsis as an on-target consequence of CRISPR\u2013Cas9 genome editing. Nat. Genet. 53, 895\u2013905 (2021).","journal-title":"Nat. Genet."},{"key":"1851_CR7","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ymthe.2020.01.001","volume":"28","author":"JL Shirley","year":"2020","unstructured":"Shirley, J. L., de Jong, Y. P., Terhorst, C. & Herzog, R. W. Immune responses to viral gene therapy vectors. Mol. Ther. 28, 709\u2013722 (2020).","journal-title":"Mol. Ther."},{"key":"1851_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav7325","volume":"11","author":"M Milani","year":"2019","unstructured":"Milani, M. et al. Phagocytosis-shielded lentiviral vectors improve liver gene therapy in nonhuman primates. Sci. Transl. Med. 11, eaav7325 (2019).","journal-title":"Sci. Transl. Med."},{"key":"1851_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1101\/gr.231936.117","volume":"28","author":"S Kim","year":"2018","unstructured":"Kim, S. et al. CRISPR RNAs trigger innate immune responses in human cells. Genome Res. 28, 367\u2013373 (2018).","journal-title":"Genome Res."},{"key":"1851_CR10","doi-asserted-by":"publisher","first-page":"e2005840","DOI":"10.1371\/journal.pbio.2005840","volume":"16","author":"B Wienert","year":"2018","unstructured":"Wienert, B., Shin, J., Zelin, E., Pestal, K. & Corn, J. E. In vitro-transcribed guide RNAs trigger an innate immune response via the RIG-I pathway. PLoS Biol. 16, e2005840 (2018).","journal-title":"PLoS Biol."},{"key":"1851_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05843-9","volume":"9","author":"JM Crudele","year":"2018","unstructured":"Crudele, J. M. & Chamberlain, J. S. Cas9 immunity creates challenges for CRISPR gene editing therapies. Nat. Commun. 9, 3497 (2018).","journal-title":"Nat. Commun."},{"key":"1851_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41591-018-0326-x","volume":"25","author":"CT Charlesworth","year":"2019","unstructured":"Charlesworth, C. T. et al. Identification of preexisting adaptive immunity to Cas9 proteins in humans. Nat. Med. 25, 249\u2013254 (2019).","journal-title":"Nat. Med."},{"key":"1851_CR13","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/s41591-018-0204-6","volume":"25","author":"DL Wagner","year":"2019","unstructured":"Wagner, D. L. et al. High prevalence of Streptococcus pyogenes Cas9-reactive T cells within the adult human population. Nat. Med. 25, 242\u2013248 (2019).","journal-title":"Nat. Med."},{"key":"1851_CR14","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1038\/s41434-021-00232-2","volume":"28","author":"DL Wagner","year":"2021","unstructured":"Wagner, D. L., Peter, L. & Schmueck-Henneresse, M. Cas9-directed immune tolerance in humans\u2014a model to evaluate regulatory T cells in gene therapy? Gene Ther. 28, 549\u2013559 (2021).","journal-title":"Gene Ther."},{"key":"1851_CR15","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nmeth.3993","volume":"13","author":"WL Chew","year":"2016","unstructured":"Chew, W. L. et al. A multifunctional AAV\u2013CRISPR\u2013Cas9 and its host response. Nat. Methods 13, 868\u2013874 (2016).","journal-title":"Nat. Methods"},{"key":"1851_CR16","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41587-020-0565-5","volume":"38","author":"J van Haasteren","year":"2020","unstructured":"van Haasteren, J., Li, J., Scheideler, O. J., Murthy, N. & Schaffer, D. V. The delivery challenge: fulfilling the promise of therapeutic genome editing. Nat. Biotechnol. 38, 845\u2013855 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1851_CR17","doi-asserted-by":"publisher","first-page":"614","DOI":"10.7150\/thno.47007","volume":"11","author":"S Zhang","year":"2021","unstructured":"Zhang, S., Shen, J., Li, D. & Cheng, Y. Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR\/Cas9 genome editing. Theranostics 11, 614\u2013648 (2021).","journal-title":"Theranostics"},{"key":"1851_CR18","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nbt.3806","volume":"35","author":"BT Staahl","year":"2017","unstructured":"Staahl, B. T. et al. Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes. Nat. Biotechnol. 35, 431\u2013434 (2017).","journal-title":"Nat. Biotechnol."},{"key":"1851_CR19","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/s41565-019-0539-2","volume":"14","author":"G Chen","year":"2019","unstructured":"Chen, G. et al. A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing. Nat. Nanotechnol. 14, 974\u2013980 (2019).","journal-title":"Nat. Nanotechnol."},{"key":"1851_CR20","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41551-017-0137-2","volume":"1","author":"K Lee","year":"2017","unstructured":"Lee, K. et al. Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair. Nat. Biomed. Eng. 1, 889\u2013901 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"1851_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature25164","volume":"553","author":"X Gao","year":"2018","unstructured":"Gao, X. et al. Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents. Nature 553, 217\u2013221 (2018).","journal-title":"Nature"},{"key":"1851_CR22","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41551-018-0252-8","volume":"2","author":"B Lee","year":"2018","unstructured":"Lee, B. et al. Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours. Nat. Biomed. Eng. 2, 497\u2013507 (2018).","journal-title":"Nat. Biomed. Eng."},{"key":"1851_CR23","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ymthe.2020.09.032","volume":"29","author":"AB Holmgaard","year":"2021","unstructured":"Holmgaard, A. B. et al. Targeted knockout of the Vegfa gene in the retina by subretinal injection of RNP complexes containing Cas9 protein and modified sgRNAs. Mol. Ther. 29, 191\u2013207 (2021).","journal-title":"Mol. Ther."},{"key":"1851_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41434-021-00258-6","volume":"29","author":"JD Gumerson","year":"2022","unstructured":"Gumerson, J. D. et al. Restoration of RPGR expression in vivo using CRISPR\/Cas9 gene editing. Gene Ther. 29, 81\u201393 (2022).","journal-title":"Gene Ther."},{"key":"1851_CR25","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1101\/gr.219089.116","volume":"27","author":"K Kim","year":"2017","unstructured":"Kim, K. et al. Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration. Genome Res. 27, 419\u2013426 (2017).","journal-title":"Genome Res."},{"key":"1851_CR26","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.coviro.2021.03.008","volume":"48","author":"BZ Igyarto","year":"2021","unstructured":"Igyarto, B. Z., Jacobsen, S. & Ndeupen, S. Future considerations for the mRNA\u2013lipid nanoparticle vaccine platform. Curr. Opin. Virol. 48, 65\u201372 (2021).","journal-title":"Curr. Opin. Virol."},{"key":"1851_CR27","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/wnan.1339","volume":"7","author":"Q Yang","year":"2015","unstructured":"Yang, Q. & Lai, S. K. Anti-PEG immunity: emergence, characteristics, and unaddressed questions. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 7, 655\u2013677 (2015).","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"1851_CR28","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.12213","volume":"5","author":"Y Cai","year":"2016","unstructured":"Cai, Y. et al. Targeted, homology-driven gene insertion in stem cells by ZFN-loaded \u2018all-in-one\u2019 lentiviral vectors. eLife 5, e12213 (2016).","journal-title":"eLife"},{"key":"1851_CR29","doi-asserted-by":"publisher","first-page":"e01911","DOI":"10.7554\/eLife.01911","volume":"3","author":"Y Cai","year":"2014","unstructured":"Cai, Y., Bak, R. O. & Mikkelsen, J. G. Targeted genome editing by lentiviral protein transduction of zinc-finger and TAL-effector nucleases. eLife 3, e01911 (2014).","journal-title":"eLife"},{"key":"1851_CR30","doi-asserted-by":"publisher","first-page":"7610","DOI":"10.1093\/nar\/gkr524","volume":"39","author":"A Izmiryan","year":"2011","unstructured":"Izmiryan, A., Basmaciogullari, S., Henry, A., Paques, F. & Danos, O. Efficient gene targeting mediated by a lentiviral vector-associated meganuclease. Nucleic Acids Res. 39, 7610\u20137619 (2011).","journal-title":"Nucleic Acids Res."},{"key":"1851_CR31","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/gt.2016.27","volume":"23","author":"JG Choi","year":"2016","unstructured":"Choi, J. G. et al. Lentivirus pre-packed with Cas9 protein for safer gene editing. Gene Ther. 23, 627\u2013633 (2016).","journal-title":"Gene Ther."},{"key":"1851_CR32","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1093\/nar\/gkz605","volume":"47","author":"P Lyu","year":"2019","unstructured":"Lyu, P., Javidi-Parsijani, P., Atala, A. & Lu, B. Delivering Cas9\/sgRNA ribonucleoprotein (RNP) by lentiviral capsid-based bionanoparticles for efficient \u2018hit-and-run\u2019 genome editing. Nucleic Acids Res. 47, e99 (2019).","journal-title":"Nucleic Acids Res."},{"key":"1851_CR33","doi-asserted-by":"publisher","first-page":"10059","DOI":"10.1093\/nar\/gkad676","volume":"51","author":"J Haldrup","year":"2023","unstructured":"Haldrup, J. et al. Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR\/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modification. Nucleic Acids Res. 51, 10059\u201310074 (2023).","journal-title":"Nucleic Acids Res."},{"key":"1851_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07845-z","volume":"10","author":"PE Mangeot","year":"2019","unstructured":"Mangeot, P. E. et al. Genome editing in primary cells and in vivo using viral-derived nanoblades loaded with Cas9-sgRNA ribonucleoproteins. Nat. Commun. 10, 45 (2019).","journal-title":"Nat. Commun."},{"key":"1851_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109207","volume":"35","author":"JR Hamilton","year":"2021","unstructured":"Hamilton, J. R. et al. Targeted delivery of CRISPR\u2013Cas9 and transgenes enables complex immune cell engineering. Cell Rep. 35, 109207 (2021).","journal-title":"Cell Rep."},{"key":"1851_CR36","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.omtn.2018.09.006","volume":"13","author":"Y Knopp","year":"2018","unstructured":"Knopp, Y. et al. Transient retrovirus-based CRISPR\/Cas9 all-in-one particles for efficient, targeted gene knockout. Mol. Ther. Nucleic Acids 13, 256\u2013274 (2018).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"1851_CR37","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/s41587-020-00781-8","volume":"39","author":"D Yin","year":"2021","unstructured":"Yin, D. et al. Targeting herpes simplex virus with CRISPR\u2013Cas9 cures herpetic stromal keratitis in mice. Nat. Biotechnol. 39, 567\u2013577 (2021).","journal-title":"Nat. Biotechnol."},{"key":"1851_CR38","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41551-020-00656-y","volume":"5","author":"S Ling","year":"2021","unstructured":"Ling, S. et al. Lentiviral delivery of co-packaged Cas9 mRNA and a Vegfa-targeting guide RNA prevents wet age-related macular degeneration in mice. Nat. Biomed. Eng. 5, 144\u2013156 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"1851_CR39","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1126\/science.abg6155","volume":"373","author":"M Segel","year":"2021","unstructured":"Segel, M. et al. Mammalian retrovirus-like protein PEG10 packages its own mRNA and can be pseudotyped for mRNA delivery. Science 373, 882 (2021).","journal-title":"Science"},{"key":"1851_CR40","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1083\/jcb.201604115","volume":"214","author":"H Ma","year":"2016","unstructured":"Ma, H. et al. CRISPR\u2013Cas9 nuclear dynamics and target recognition in living cells. J. Cell Biol. 214, 529\u2013537 (2016).","journal-title":"J. Cell Biol."},{"key":"1851_CR41","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/nbt.4172","volume":"36","author":"LW Koblan","year":"2018","unstructured":"Koblan, L. W. et al. Improving cytidine and adenine base editors by expression optimization and ancestral reconstruction. Nat. Biotechnol. 36, 843\u2013846 (2018).","journal-title":"Nat. Biotechnol."},{"key":"1851_CR42","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/crispr.2020.0095","volume":"4","author":"P Lyu","year":"2021","unstructured":"Lyu, P. et al. Adenine base editor ribonucleoproteins delivered by lentivirus-like particles show high on-target base editing and undetectable RNA off-target activities. CRISPR J. 4, 69\u201381 (2021).","journal-title":"CRISPR J."},{"key":"1851_CR43","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","volume":"185","author":"S Banskota","year":"2022","unstructured":"Banskota, S. et al. Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins. Cell 185, 250\u2013265.e16 (2022).","journal-title":"Cell"},{"key":"1851_CR44","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.cell.2020.02.028","volume":"180","author":"RS Apte","year":"2020","unstructured":"Apte, R. S. Reducing treatment burden in AMD. Cell 180, 1033 (2020).","journal-title":"Cell"},{"key":"1851_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3389\/fgeed.2020.594984","volume":"2","author":"SH Chung","year":"2020","unstructured":"Chung, S. H., Sin, T.-N., Ngo, T. & Yiu, G. CRISPR technology for ocular angiogenesis. Front. Genome Ed. 2, 29 (2020).","journal-title":"Front. Genome Ed."},{"key":"1851_CR46","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/pharmaceutics13020219","volume":"13","author":"S Koponen","year":"2021","unstructured":"Koponen, S., Kokki, E., Kinnunen, K. & Yla-Herttuala, S. Viral-vector-delivered anti-angiogenic therapies to the eye. Pharmaceutics 13, 219 (2021).","journal-title":"Pharmaceutics"},{"key":"1851_CR47","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/sj.gt.3302485","volume":"12","author":"O Gr\u00fcter","year":"2005","unstructured":"Gr\u00fcter, O. et al. Lentiviral vector-mediated gene transfer in adult mouse photoreceptors is impaired by the presence of a physical barrier. Gene Ther. 12, 942\u2013947 (2005).","journal-title":"Gene Ther."},{"key":"1851_CR48","doi-asserted-by":"publisher","first-page":"604205","DOI":"10.3389\/fimmu.2020.604205","volume":"11","author":"W Kwon","year":"2020","unstructured":"Kwon, W. & Freeman, S. A. Phagocytosis by the retinal pigment epithelium: recognition, resolution, recycling. Front. Immunol. 11, 604205 (2020).","journal-title":"Front. Immunol."},{"key":"1851_CR49","doi-asserted-by":"publisher","unstructured":"Yin, D. et al. Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers. Nat. Biomed. Eng. https:\/\/doi.org\/10.1038\/s41551-024-01208-4 (2024).","DOI":"10.1038\/s41551-024-01208-4"},{"key":"1851_CR50","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/hum.2009.179","volume":"22","author":"S Kato","year":"2011","unstructured":"Kato, S. et al. A lentiviral strategy for highly efficient retrograde gene transfer by pseudotyping with fusion envelope glycoprotein. Hum. Gene Ther. 22, 197\u2013206 (2011).","journal-title":"Hum. Gene Ther."},{"key":"1851_CR51","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.celrep.2016.03.067","volume":"15","author":"EJ Kim","year":"2016","unstructured":"Kim, E. J., Jacobs, M. W., Ito-Cole, T. & Callaway, E. M. Improved monosynaptic neural circuit tracing using engineered rabies virus glycoproteins. Cell Rep. 15, 692\u2013699 (2016).","journal-title":"Cell Rep."},{"key":"1851_CR52","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1093\/bioinformatics\/btu048","volume":"30","author":"S Bae","year":"2014","unstructured":"Bae, S., Park, J. & Kim, J.-S. Cas-OFFinder: a fast and versatile algorithm that searches for potential off-target sites of Cas9 RNA-guided endonucleases. Bioinformatics 30, 1473\u20131475 (2014).","journal-title":"Bioinformatics"},{"key":"1851_CR53","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"PD Hsu","year":"2013","unstructured":"Hsu, P. D. et al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat. Biotechnol. 31, 827\u2013832 (2013).","journal-title":"Nat. Biotechnol."},{"key":"1851_CR54","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.3389\/fimmu.2019.02522","volume":"10","author":"Z Grossman","year":"2019","unstructured":"Grossman, Z. Immunological paradigms, mechanisms, and models: conceptual understanding is a prerequisite to effective modeling. Front. Immunol. 10, 2522 (2019).","journal-title":"Front. Immunol."},{"key":"1851_CR55","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3389\/fimmu.2012.00296","volume":"3","author":"I Benhar","year":"2012","unstructured":"Benhar, I., London, A. & Schwartz, M. The privileged immunity of immune privileged organs: the case of the eye. Front. Immunol. 3, 296 (2012).","journal-title":"Front. Immunol."},{"key":"1851_CR56","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang, J. et al. Guidelines and definitions for research on epithelial\u2013mesenchymal transition. Nat. Rev. Mol. Cell Biol. 21, 341\u2013352 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1851_CR57","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1038\/s41587-023-02085-z","volume":"42","author":"JR Hamilton","year":"2024","unstructured":"Hamilton, J. R. et al. In vivo human T cell engineering with enveloped delivery vehicles. Nat. Biotechnol. 42, 1684\u20131692 (2024).","journal-title":"Nat. Biotechnol."},{"key":"1851_CR58","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.3390\/v12091016","volume":"12","author":"A Gutierrez-Guerrero","year":"2020","unstructured":"Gutierrez-Guerrero, A., Cosset, F. L. & Verhoeyen, E. Lentiviral vector pseudotypes: precious tools to improve gene modification of hematopoietic cells for research and gene therapy. Viruses 12, 1016 (2020).","journal-title":"Viruses"},{"key":"1851_CR59","first-page":"5702","volume":"4","author":"AM Frank","year":"2020","unstructured":"Frank, A. M. et al. Combining T-cell-specific activation and in vivo gene delivery through CD3-targeted lentiviral vectors. Blood Adv. 4, 5702\u20135715 (2020).","journal-title":"Blood Adv."},{"key":"1851_CR60","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.ymthe.2020.05.005","volume":"28","author":"S Agarwal","year":"2020","unstructured":"Agarwal, S. et al. In vivo generation of CAR T cells selectively in human CD4+ lymphocytes. Mol. Ther. 28, 1783\u20131794 (2020).","journal-title":"Mol. Ther."},{"key":"1851_CR61","doi-asserted-by":"publisher","first-page":"3210","DOI":"10.1038\/s41596-021-00510-8","volume":"16","author":"T Weidner","year":"2021","unstructured":"Weidner, T. et al. Genetic in vivo engineering of human T lymphocytes in mouse models. Nat. Protoc. 16, 3210\u20133240 (2021).","journal-title":"Nat. Protoc."},{"key":"1851_CR62","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884\u2013i890 (2018).","journal-title":"Bioinformatics"},{"key":"1851_CR63","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gr.209601.116","volume":"27","author":"T Smith","year":"2017","unstructured":"Smith, T., Heger, A. & Sudbery, I. UMI-tools: modeling sequencing errors in unique molecular identifiers to improve quantification accuracy. Genome Res. 27, 491\u2013499 (2017).","journal-title":"Genome Res."},{"key":"1851_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18548-9","volume":"11","author":"A Lundin","year":"2020","unstructured":"Lundin, A. et al. Development of an ObLiGaRe doxycycline inducible Cas9 system for pre-clinical cancer drug discovery. Nat. Commun. 11, 4903 (2020).","journal-title":"Nat. Commun."},{"key":"1851_CR65","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","volume":"78","author":"Y Zhang","year":"2013","unstructured":"Zhang, Y. et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78, 785\u2013798 (2013).","journal-title":"Neuron"},{"key":"1851_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41240-7","volume":"14","author":"B Bestas","year":"2023","unstructured":"Bestas, B. et al. A type II-B Cas9 nuclease with minimized off-targets and reduced chromosomal translocations in vivo. Nat. Commun. 14, 5474 (2023).","journal-title":"Nat. Commun."},{"key":"1851_CR67","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224\u2013226 (2019).","journal-title":"Nat. Biotechnol."},{"key":"1851_CR68","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ymeth.2017.03.021","volume":"121","author":"AM Jacobi","year":"2017","unstructured":"Jacobi, A. M. et al. Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes. Methods 121\u2013122, 16\u201328 (2017).","journal-title":"Methods"},{"key":"1851_CR69","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/j.ymthe.2021.01.024","volume":"29","author":"M Zabulica","year":"2021","unstructured":"Zabulica, M. et al. Correction of a urea cycle defect after ex vivo gene editing of human hepatocytes. Mol. Ther. 29, 1903\u20131917 (2021).","journal-title":"Mol. Ther."}],"container-title":["Nature Nanotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41565-024-01851-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41565-024-01851-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41565-024-01851-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T16:03:06Z","timestamp":1745337786000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41565-024-01851-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1851"],"URL":"https:\/\/doi.org\/10.1038\/s41565-024-01851-7","relation":{},"ISSN":["1748-3387","1748-3395"],"issn-type":[{"value":"1748-3387","type":"print"},{"value":"1748-3395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,10]]},"assertion":[{"value":"28 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S. Ling and Y.C. have a patent (ZL201910979334.0) on RIDE applied via Shanghai Jiao Tong University. Y.C. is a co-founder and advisor of BDGENE Therapeutics. T.M.S., A.L., B.B., N.S., J.L.T., M.F. and P.A. are employees and shareholders of AstraZeneca. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}